BioNTech-Pfizer say Covid vaccine 100% effective on 12-15 year olds

13 Sept 07:41 Key points summarised by AI

BioNTech-Pfizer announced their COVID-19 vaccine demonstrated 100% efficacy and robust antibody responses in Phase 3 trials involving 2,260 adolescents aged 12-15.
The companies plan to submit these positive data to regulators like the FDA in the coming weeks, aiming for authorization to vaccinate this age group before the upcoming school year.
This high protection for teens is particularly encouraging given the spread of variants like B.1.1.7 (UK variant), according to BioNTech's CEO.
BioNTech is on track to produce 2.5 billion vaccine doses this year, driven by new manufacturing sites and improved efficiency, with trials for children as young as six months old already underway.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.